Remote Anchorage for the Severely Atrophic Maxilla: A Critical Review of Zygomatic and Pterygoid Implants and a Sinus-Level Registry Protocol to Test Whether Implant Path, Not Implant Count, Determines Rhinosinusitis Risk
- Paper type
- Critical review with an embedded prospective registry protocol
- Status
- Original Work · Working Paper
- Keywords:
- zygomatic implants · pterygoid implants · atrophic maxilla · maxillary sinusitis · extrasinus technique · zygoma anatomy-guided approach · graftless rehabilitation · registry
Contents
- 1Introduction and Clinical Significance
- 2Critical Review of the Established Literature
- 3Identification of the Specific Research Gap
- 4Scientific Objective and Hypotheses
- 5Theoretical Foundation: Why Path Should Matter
- 6Methodology
- 7Evidence Synthesis and Explicitly Labeled Theoretical Predictions
- 8Discussion: Mechanisms and Competing Explanations
- 9Implications for Implant Surgery and Restorative Dentistry
- 10Technical and Clinical Limitations
- 11Proposed Clinical Validation
- 12Future Research Directions
- 13Evidence-Calibrated Conclusion
Abstract
Background: Zygomatic and pterygoid implants allow fixed rehabilitation of the severely atrophic maxilla without sinus grafting. Systematic reviews report cumulative survival of roughly 95 percent for both. Rhinosinusitis is the leading complication of zygomatic implants and may present years after placement. Surgical techniques differ in whether the implant traverses the sinus cavity, yet outcomes are usually reported per implant and without regard to path.
Objective: To appraise the evidence on survival and complications of zygomatic and pterygoid implants, to identify the determinants of sinus morbidity, and to design a study able to test a path-based explanation.
Methods: Critical narrative review prioritizing systematic reviews and consensus reports, prospective cohorts, the one multicenter randomized trial against grafting, and anatomical studies. A risk model was formulated with the sinus as the unit of observation. A prospective registry was specified with postoperative cone-beam computed tomographic classification of each implant's path, membrane status, and ostial patency, and with patient-reported sinonasal outcomes.
Findings: Survival evidence is consistent but derives largely from retrospective series from experienced centers, with heterogeneous follow-up. Sinusitis incidence varies widely between reports, reflecting differing definitions and surveillance. Evidence that extrasinus placement reduces sinusitis is limited and non-randomized, and extrasinus paths bring soft-tissue complications of their own. For pterygoid implants, survival is high and complications are infrequently reported, with little prospective data. We hypothesize that the sinus-level rate of rhinosinusitis is at least 50 percent lower when no implant traverses the sinus cavity, and that the number of implants per sinus adds little once path and perforation are accounted for. A rate ratio whose confidence interval includes one would refute the first claim.
Conclusions: Remote anchorage is an established option for severe maxillary atrophy when performed by trained surgeons. Its principal long-term morbidity is plausibly a function of surgical path, a proposition that existing data cannot confirm and a registry could. No patient data are reported here.
Keywords: zygomatic implants; pterygoid implants; atrophic maxilla; maxillary sinusitis; extrasinus technique; zygoma anatomy-guided approach; graftless rehabilitation; registry
1. Introduction and Clinical Significance
The edentulous posterior maxilla resorbs in two directions at once: the alveolar crest recedes and the sinus pneumatizes. In advanced cases the residual bone beneath the sinus is a few millimeters thick, and conventional implants cannot be placed without augmentation. Sinus floor elevation and onlay grafting address the deficiency directly, at the cost of additional surgery, healing time measured in months, donor-site morbidity when autogenous bone is used, and a period without a fixed prosthesis [1, 2]. Remote anchorage takes the opposite approach. It leaves the deficient alveolus as it is and seeks fixation in bone that does not resorb with tooth loss: the body of the zygoma, and the pterygomaxillary buttress formed by the maxillary tuberosity, the pyramidal process of the palatine bone, and the pterygoid process of the sphenoid.
The zygomatic implant was introduced by Brånemark for patients with extreme atrophy or maxillary defects, with a path from the palatal alveolar crest through the maxillary sinus into the zygoma [3]. Pterygoid implants, placed through the tuberosity into the pterygoid plates, were developed in parallel as a means of obtaining posterior support without entering the sinus [4]. Both permit immediate fixed rehabilitation in patients who would otherwise require staged grafting, and both have moved from salvage procedures toward first-line options in some centers [5, 6].
The clinical question has shifted accordingly. It is no longer whether these implants integrate; the survival literature answers that. It is what they cost the patient over decades, in which patients that cost is lowest, and how the choice between remote anchorage and augmentation should be made. For zygomatic implants the cost is dominated by sinus morbidity. For pterygoid implants it is poorly documented. This paper concentrates on the first, where a specific mechanistic hypothesis can be stated and tested, and reviews the second to define what is missing.
2. Critical Review of the Established Literature
Zygomatic implants: survival
The largest systematic review of zygomatic implants pooled 68 studies comprising 4,556 implants in 2,161 patients, with 103 failures and a 12-year cumulative survival of about 95 percent; most failures occurred within the first months after placement [7]. Earlier systematic reviews reported similar figures from smaller bases [8, 9]. A meta-analysis of long-term outcomes commissioned for a recent consensus conference likewise found high implant and prosthesis survival over mean follow-up exceeding five years [10], and companion reviews addressed indications and surgical technique [11, 12]; the resulting consensus report endorsed zygomatic implants for the severely atrophic maxilla while calling for standardized reporting of complications [6]. Prospective single-center cohorts have documented outcomes to seven years and beyond [13].
A multicenter randomized controlled trial compared immediately loaded zygomatic implants with conventional implants placed in augmented atrophic maxillae and reported one-year post-loading results, with significantly fewer prosthesis and implant failures in the zygomatic group and significantly more patients experiencing complications [14]. It remains the only randomized comparison with grafting, and its follow-up is short relative to the latency of sinus complications.
The limitations of the survival literature are well recognized by its own authors: predominance of retrospective case series, reporting from a small number of expert centers, variable follow-up with substantial attrition in the longer series, and analysis at the implant level without adjustment for clustering within patients.
Zygomatic implants: complications
In the pooled analysis, postoperative sinusitis was the most frequent complication at 2.4 percent of implants, followed by soft-tissue infection, paresthesia, and oroantral fistula; the authors cautioned that sinusitis can develop several years after surgery and that the figures were probably underestimates because many studies did not mention whether complications occurred [7]. A systematic review of surgical complications likewise identified sinusitis, at about 4 percent, and failure of osseointegration as the most frequent [15]. The meta-analysis of long-term outcomes, restricted to studies with at least three years of follow-up, estimated the prevalence of sinusitis at 14.2 percent (95% confidence interval 8.8 to 22.0) at five years [10]. The sixfold gap between that figure and the implant-level proportion is a measure of how much the answer depends on the denominator, the definition, and the duration of observation. A cohort examined before and after zygomatic surgery found that radiological sinus findings rose from 12 to 46 percent of patients while the proportion with elevated symptom scores did not change significantly [16]. Individual series illustrate the range: an early report of zygomatic and conventional implants supporting cross-arch bridges in 16 patients described recurrent sinusitis and poor soft-tissue conditions at the palatal emergence in a notable proportion [17], whereas a clinical and radiological study of immediately loaded zygomatic implants found few sinus reactions [18], and sinuscopic examination of patients with titanium implants traversing the nose and sinuses found no signs of increased inflammatory reaction around the implants [19].
Other complications are rare and serious. Orbital penetration, infraorbital nerve injury, and intracranial entry have been reported, and reviews of complication management emphasize preoperative imaging, direct visualization of the zygoma, and experience [20]. The zygoma itself provides a limited volume of dense bone, with dimensions that vary between individuals [21].
Surgical path
Three families of technique differ in the implant's relation to the sinus. In the original intrasinus technique, a window is opened in the lateral sinus wall, the membrane is reflected where possible, and the implant passes through the sinus cavity from a palatal entry [3]. The sinus slot technique places the implant along a slot in the lateral wall, bringing the platform closer to the crest and the implant body partly outside the cavity [22]. In extramaxillary or extrasinus placement, the implant is anchored only in the zygoma and lies lateral to the maxilla, with its coronal part covered by soft tissue alone [23]. Aparicio's anatomy-guided approach formalized the choice: the path is determined by the curvature of the lateral maxillary wall and the position of the alveolar crest relative to the zygomatic buttress, classified in five types from fully intrasinus to fully extramaxillary [24], and a comparison of patients treated by the anatomy-guided approach with an earlier cohort treated by the classical technique found similar implant survival and a higher proportion of patients free of signs and symptoms of rhinosinusitis in the anatomy-guided group (about 76 versus 55 percent), and proposed a system for reporting rhinosinusitis that combines a radiographic sinus score with a clinical questionnaire [25]. A scheme for reporting success that includes sinus status alongside implant stability, soft-tissue condition, and prosthetic position has been proposed [5].
The rationale for moving the implant out of the sinus is prosthetic as well as biological: a crestal instead of palatal emergence improves prosthesis contour. The biological rationale, fewer sinus complications, is plausible and supported mainly by comparisons of sequential cohorts that differ in era, implant surface, loading protocol, and follow-up. Extrasinus placement introduces its own risks, namely mucosal recession and exposure of threads on the lateral aspect.
Quad zygoma
When anterior alveolar bone is also inadequate, two zygomatic implants are placed on each side. A systematic review of prostheses supported by four zygomatic implants reported high implant survival and few surgical complications, of which orbital perforation was the most significant, from a small evidence base [26], and technique reviews describe the demands of fitting two implants within each zygoma [27]. The anterior implant passes close to the orbit, and navigation or guided approaches have been explored to control its trajectory: a cadaver study found clinically relevant deviations with stereolithographic guides for zygomatic implants [28], and a pilot clinical study reported the accuracy achievable with real-time navigation for quad zygomatic placement [29].
Pterygoid implants
A systematic review of implants in the pterygoid region found high survival and few reported complications across mostly retrospective studies [30], and an update restricted to modern roughened-surface implants reported 39 failures among 911 implants with cumulative survival of about 95 percent at six years [31]. A meta-analysis of 1,893 pterygoid implants estimated survival at approximately 95 percent [32]. A recent systematic review distinguishing pterygoid from tuberosity implants found lower ten-year cumulative survival for the former (about 93 versus 97 percent) and, in unadjusted comparison, higher survival with immediate loading, a finding most likely explained by case selection and splinting [33]. Large single-center series describe hundreds of pterygomaxillary implants placed for fixed prostheses [4, 34], a modified drilling protocol and its radiological verification [35], and three-year implant and prosthesis survival in the atrophic posterior maxilla [36]. Narrative reviews summarize the indication as avoidance of sinus grafting and distal cantilevers [37].
The anatomical basis is the column of dense bone at the pterygomaxillary junction. A cone-beam tomographic study of 100 patients measured the dimensions of this region and the angulation required to engage it [38]. Structures at risk are the descending palatine vessels medially and the pterygoid venous plexus and maxillary artery branches posteriorly; significant bleeding is the feared intraoperative event, and its incidence in the literature is low but based on series from high-volume operators. Prosthetic access to a platform at the tuberosity, hygiene, and the long-term condition of the soft tissue around a steeply inclined implant are sparsely reported.
The comparator
Augmentation of the maxillary sinus is itself well supported. A Cochrane review found that implants placed in augmented sinuses perform well and that, where residual height permits, short implants may be an alternative with fewer complications [2]; an evidence review of hard-tissue augmentation techniques ranked sinus grafting among the best documented [1]. The choice between grafting and remote anchorage therefore arises mainly in the extreme atrophy that grafting handles least well and in patients for whom treatment time, donor-site surgery, or prior graft failure weigh heavily. Systematic pretreatment evaluation schemes allocate patients according to the zones of the maxilla in which bone is available [39].
3. Identification of the Specific Research Gap
Established: zygomatic and pterygoid implants integrate and survive at rates near 95 percent over medium-term follow-up in the hands of experienced surgeons; sinusitis is the most common complication of zygomatic implants and may be delayed; several surgical paths exist.
Uncertain: the true incidence of sinus morbidity, its determinants, and whether it differs by path; the long-term soft-tissue behavior of extrasinus and pterygoid implants; and the comparative effectiveness of remote anchorage and grafting on patient-centered outcomes beyond one year.
Current methods cannot resolve these uncertainties. Sinusitis is defined variously as symptoms, as radiographic opacification, or as the need for intervention, and is often ascertained only when a patient complains. Incidence is reported per implant, although the sinus is the organ at risk and one or two implants may share it. Follow-up is uneven, so proportions and not rates are reported, which understates a complication with long latency. Technique is recorded as the surgeon's intended approach; the actual relation of each implant to the sinus cavity, membrane, and ostium is seldom verified on postoperative imaging. Preexisting sinus disease is rarely documented. Comparisons between techniques use historical controls. And because nearly all data come from pioneers of each technique, operator and technique are confounded.
The specific gap is a prospective dataset in which every sinus is characterized before surgery, every implant's realized path is classified from postoperative tomography, and sinus outcomes are measured by validated instruments at fixed intervals with person-time accounting.
4. Scientific Objective and Hypotheses
The objective is to determine whether the risk of maxillary rhinosinusitis after zygomatic implant placement is governed by the anatomical relation between implant and sinus.
Hypothesis H8a (path). With the maxillary sinus as the unit of analysis, the incidence rate of rhinosinusitis over five years is at least 50 percent lower in sinuses in which no zygomatic implant traverses the cavity (fully extrasinus paths) than in sinuses traversed by at least one implant, after adjustment for preexisting sinus disease, smoking, and center. H8a is falsified if the adjusted rate ratio has a 95% confidence interval that includes 1; it is supported only in its stated magnitude if the upper confidence limit lies at or below 0.5, and otherwise is supported in direction alone.
Hypothesis H8b (perforation). Among traversed sinuses, the rate is higher where the Schneiderian membrane was perforated or the implant lies exposed within the cavity than where the implant is covered by intact membrane. H8b is falsified by a rate ratio whose interval includes 1.
Hypothesis H8c (count). Once path and perforation are accounted for, the presence of two implants in a sinus as opposed to one does not raise the rate by more than 25 percent. H8c is falsified if the lower confidence limit of the rate ratio for two versus one implant exceeds 1.25.
A secondary, exploratory objective concerns the trade-off: whether extrasinus paths exchange sinus morbidity for soft-tissue recession and thread exposure, in which case the net benefit depends on the relative weight patients place on the two.
5. Theoretical Foundation: Why Path Should Matter
Sinus physiology
The maxillary sinus drains through an ostium high on its medial wall into the middle meatus, and drainage depends on mucociliary transport toward that ostium. Sinusitis of dental or iatrogenic origin arises through three mechanisms relevant to a transsinus implant. The first is a persistent oroantral communication along the implant, where the palatal or crestal mucosa fails to seal around the coronal portion and oral flora enter the antrum. The second is impairment of mucociliary clearance by a foreign body exposed within the cavity, on which mucus stagnates and biofilm forms. The third is obstruction of the ostiomeatal unit by postoperative edema or by mucosal thickening. The first two depend directly on whether the implant passes through the cavity and whether it is covered by membrane; the third depends more on the patient's preexisting anatomy and mucosal disease.
A path-stratified risk model
Let sinus s be observed for time Ts and experience Ys episodes of rhinosinusitis meeting the case definition. We model the count as Poisson with rate λs, where
log λ_s = β_0 + β_1 P_s + β_2 M_s + β_3 N_s + γ^T z_s + u_(c(s)) + v_(p(s)) (1)
with offset log Ts. Ps is an indicator that at least one implant traverses the sinus cavity; Ms is an indicator of membrane perforation or bare implant exposure within the cavity (defined only when Ps = 1); Ns indicates two implants versus one associated with that sinus; zs is a vector of covariates (preexisting mucosal thickening or ostial obstruction, smoking, history of sinus surgery, immediate loading); u is a random effect for center and v a random effect for patient, since two sinuses in one patient share host factors. The rate ratios of interest are exp(β1) for path, exp(β2) for perforation, and exp(β3) for count. H8a asserts exp(β1) of 2 or more for traversed relative to non-traversed sinuses, equivalently 0.5 or less in the reverse direction.
Why implant-level proportions mislead
Reported complication proportions are of the form events divided by implants. Two distortions follow. First, when two implants share a sinus and that sinus becomes infected, implant-level reporting counts either one or two events inconsistently. Second, if the hazard is constant at rate λ per sinus-year, the proportion of sinuses affected by time t is
F(t) = 1 - e^(-λ t) (2)
so that studies with different follow-up report different proportions for the same underlying rate. As a purely arithmetic illustration, a rate of 0.01 per sinus-year gives 1 percent at one year and about 9.5 percent at ten; a pooled proportion from studies of mixed duration is not interpretable as either. If the hazard is not constant, for instance if late failures of the palatal soft-tissue seal produce a rising hazard, the distortion is greater. Rates with person-time denominators, and time-to-event methods, are required.
Count versus path
If sinusitis arose independently from each implant with per-implant probability p over a given period, a sinus with n implants would be affected with probability
1 - (1 - p)^n (3)
which for small p is close to np: two implants would nearly double the risk. H8c proposes instead that the risk is a property of the breach, whether the cavity has been entered and left with exposed hardware or a communication, and that a second implant through the same window adds comparatively little. The alternative, proportionality to count, is biologically reasonable if each palatal emergence is an independent potential communication. The two possibilities make different quantitative predictions, which is what allows the registry to discriminate between them.
The competing trade-off
Extrasinus placement moves the implant's coronal and middle thirds from beneath sinus membrane to beneath buccal mucosa. Mucosa over a prominent implant body is subject to tension, thin biotype, and trauma, and recession exposes threads to the oral cavity. A complete account of path therefore requires at least two outcomes with opposite expected dependence on path. Denoting the rates of sinus events and of soft-tissue dehiscence by λsin and λsoft, and their respective disutilities to the patient by wsin and wsoft, the expected morbidity burden per unit time for a given path is
B = w_(sin) λ_(sin) + w_(soft) λ_(soft) (4)
The weights are not known and must be elicited from patients; the expression is a reminder that a technique which halves sinus events is preferable only if it does not raise the weighted soft-tissue burden by more.
6. Methodology
Review methods
The review is narrative and critical. Systematic reviews, the recent consensus report, the single randomized trial, prospective cohorts, and anatomical studies were prioritized. No meta-analysis was performed. Pooled figures quoted are those of the cited reviews.
Registry design
The proposed study is a prospective, multicenter, observational registry reported according to STROBE [40]. Participating centers enroll consecutive patients receiving one or more zygomatic implants for any indication; a parallel module enrolls patients receiving pterygoid implants. Centers with differing preferred techniques are recruited deliberately so that path varies within and between centers, and each center commits to enrolling all eligible patients to avoid selective reporting. A minimum of ten centers is sought so that technique is not perfectly confounded with operator.
Baseline assessment
Before surgery each patient completes the 22-item Sinonasal Outcome Test, a validated patient-reported measure of rhinosinusitis symptoms [41], and undergoes cone-beam computed tomography including the ostiomeatal units. Each sinus is scored for mucosal thickening and opacification using an established radiological staging system [42], and ostial patency is recorded. Smoking, history of sinus disease or surgery, and prior grafting are documented. The maxilla is classified by the anatomy-guided scheme [24] and by residual bone zones [39].
Exposure classification
The exposure is the realized path, determined from cone-beam computed tomography obtained within three months of surgery and read by two calibrated examiners blind to outcome. For each implant the following are recorded: entry point (palatal, crestal, buccal); length of implant within the sinus cavity; whether that length is covered by membrane or bone or lies bare within the lumen; distance from the implant to the ostium; and position of the apex relative to the zygoma and orbit. Each sinus is then classified as not traversed, traversed with coverage, or traversed with exposure (Table 1). Intraoperative membrane perforation as noted by the surgeon is recorded separately. Agreement between examiners is reported.
| Class | Definition | Model coding |
|---|---|---|
| 0 | No implant enters the sinus cavity; implant body lateral to the lateral sinus wall or within bone throughout | P = 0 |
| 1 | Implant passes along or through the lateral wall; any intrasinus portion covered by bone or by intact membrane with no air-implant interface | P = 1, M = 0 |
| 2 | Implant traverses the cavity with a bare implant-air interface, or membrane perforation documented | P = 1, M = 1 |
| Modifier | One or two zygomatic implants associated with the sinus | N = 0 or 1 |
| Modifier | Palatal emergence with mucosal seal intact or deficient at 3 months | Covariate |
Outcomes
The primary outcome is incident rhinosinusitis of the operated sinus, defined by a composite that requires both symptoms and objective evidence: a clinically meaningful worsening of the sinonasal questionnaire score from baseline together with new or increased opacification on imaging or endoscopic confirmation, or any sinus intervention (antibiotic course prescribed for sinusitis with objective findings, endoscopic surgery, implant removal for sinus reasons). The requirement for both components is intended to exclude asymptomatic radiographic thickening, which is common and of doubtful significance, and symptoms without objective basis. Questionnaires are administered annually; imaging is obtained at one, three, and five years and when symptoms arise. Secondary outcomes are oroantral communication; soft-tissue dehiscence or thread exposure; peri-implant soft-tissue status at the emergence; implant failure; prosthesis failure; neurosensory disturbance; and patient-reported oral health-related quality of life. For the pterygoid module, outcomes are implant failure, intraoperative bleeding requiring intervention, postoperative trismus or pain beyond a defined period, prosthetic complications, and soft-tissue status.
Analysis
The primary analysis fits the mixed-effects Poisson model of Equation 1 to sinus-level data, with sensitivity analyses using a negative binomial distribution and a Cox model for time to first event with shared frailty for patient. Losses to follow-up are described by exposure class, and inverse-probability-of-censoring weights are applied in a sensitivity analysis. Because path is chosen according to anatomy, confounding by indication is addressed by adjusting for the anatomical class that drives the choice and, in a secondary analysis, by restricting to anatomical classes in which more than one path is feasible and practice varies between centers. The soft-tissue outcome is analyzed in the same framework so that the trade-off of Section 5.5 can be displayed.
Sample size
Power depends on events. For a comparison of two Poisson rates with equal person-time in each group, the total number of events needed to detect a rate ratio R with two-sided type I error α and power 1 − β is approximately
D = (4 (z_(1-α/2) + z_(1-β))^2)/((ln R)^2) (5)
where z denotes the standard normal quantile. For R = 0.5 this gives roughly 65 events in total. If the rate in traversed sinuses were 0.02 per sinus-year, an assumption for planning that is of the order implied by the five-year prevalence quoted above and must be revised when registry data accrue, and half that in non-traversed sinuses, about 4,400 sinus-years of observation would be needed, for example 440 patients with two operated sinuses followed for five years, before allowance for clustering and attrition. Inflating for a modest design effect and 20 percent loss suggests a target of about 650 patients. The event rate is the principal uncertainty.
7. Evidence Synthesis and Explicitly Labeled Theoretical Predictions
Synthesis
Table 2 summarizes what can and cannot be concluded from the literature reviewed. The assessments are qualitative judgments by the authors and are not derived from a formal grading system.
| Question | What the evidence shows | Principal limitation |
|---|---|---|
| Do zygomatic implants survive? [7, 10] | Cumulative survival about 95 percent at 12 years in pooled series | Retrospective, expert centers, implant-level analysis, attrition |
| How common is sinusitis? [7, 10, 16] | Most frequent complication; 2.4 percent of implants in one pooled analysis and 14.2 percent prevalence at five years in another; radiological findings far more common than symptoms | Inconsistent definitions; passive ascertainment; proportions not rates |
| Does extrasinus placement reduce sinusitis? [23, 25] | Suggested by sequential cohorts | Historical controls; confounding by era and operator |
| Are zygomatic implants better than grafting? [14] | One randomized trial, one-year results favoring fewer failures | Short follow-up; single trial |
| Do pterygoid implants survive? [31, 32] | About 95 percent in pooled series | Retrospective; complications under-reported |
| What is pterygoid implant morbidity? [30, 33] | Few complications reported | Absence of systematic ascertainment |
Theoretical predictions
The following are predictions from Section 5, not findings.
Prediction 1. The sinus-level rate of composite rhinosinusitis will be highest in class 2, intermediate in class 1, and lowest in class 0.
Prediction 2. Preexisting ostial obstruction or marked mucosal thickening will raise the rate in all classes, and its effect will be at least as large as that of path. If so, preoperative sinus assessment and, where indicated, otolaryngologic treatment would be as important as surgical technique.
Prediction 3. A deficient palatal mucosal seal at three months will predict later sinusitis in traversed sinuses, identifying oroantral communication as the dominant mechanism.
Prediction 4. The rate ratio for two versus one implant per sinus will be closer to 1 than to 2.
Prediction 5. Soft-tissue dehiscence will be more frequent in class 0 than in classes 1 and 2, so that the classes will not be ordered identically for all outcomes.
Prediction 6. The hazard of sinusitis will not be constant: an early peak related to surgery will be followed by a low and possibly rising late hazard related to seal breakdown.
8. Discussion: Mechanisms and Competing Explanations
The path hypothesis is attractive because it is anatomically sensible and because the field has already acted on it, moving progressively toward extrasinus placement. Precisely for that reason it needs testing. Three competing explanations could account for lower sinusitis in recent extrasinus series without any causal effect of path.
The first is era. Early intrasinus series used machined implants, two-stage protocols with removable interim dentures pressing on the palatal emergence, and less sophisticated imaging; later series differ in all of these. The second is experience. Extrasinus techniques were introduced by surgeons who had already placed many zygomatic implants. The third is ascertainment. Series reporting a new technique often have shorter follow-up, and sinusitis is a late complication [7]. A concurrent multicenter registry with adjustment for center and with person-time analysis addresses the first and third directly and the second partly.
A more fundamental alternative holds that sinusitis after zygomatic surgery is chiefly a matter of the patient's sinus and not of the implant. Many patients with atrophic maxillae have asymptomatic mucosal thickening, and the sinuscopic observation that implants within the sinus were not surrounded by inflammation [19] suggests that a foreign body in the antrum is tolerated when drainage is intact. On this view, ostial patency before surgery is the determinant, the implant is at most a cofactor, and the path effect will be small once baseline sinus status is included. The registry measures baseline status for that reason, and Prediction 2 allows for this outcome. Were it confirmed, the clinical implication would be preoperative sinus evaluation and treatment, with path chosen on prosthetic grounds.
The count question deserves comment because quad zygoma protocols are increasingly used. If each palatal emergence is an independent leak, four implants carry about twice the sinus risk of two. If the breach is the event, the difference is small. The systematic review of quad zygoma protocols reported few complications [26], which is compatible with the second reading but comes from a small and selected evidence base in which sinus outcomes were not systematically ascertained.
The composite outcome is a deliberate choice with drawbacks. Requiring both symptoms and objective evidence reduces sensitivity, but the alternative is to count radiological change that patients do not perceive, which was several times more frequent than symptomatic change in the one before-and-after cohort [16]. Using intervention as part of the definition makes the outcome dependent on local thresholds for treatment. Radiographic thickening alone would be more sensitive and more reproducible but of uncertain meaning. Reporting each component separately, as proposed systems for rhinosinusitis reporting after zygomatic surgery recommend [25], allows readers to apply their own definition.
For pterygoid implants, the discussion is necessarily about absence of evidence. High survival is reported consistently [31, 32]. The lack of reported complications may reflect a safe procedure or a literature composed of retrospective series in which complications were not sought. The finding that pterygoid implants had lower survival than tuberosity implants [33] raises the question of whether engagement of the pterygoid plates, the defining feature of the technique, is beneficial, or whether the comparison reflects worse baseline anatomy in patients who required the longer path. A registry module with standardized recording of bleeding, pain, trismus, and prosthetic maintainability would establish basic facts that are missing.
Finally, comparisons with grafting are distorted by the choice of endpoint. Implant survival favors neither strongly. The outcomes on which the strategies plausibly differ are time to fixed function, number of surgical episodes, donor-site morbidity, sinus health at ten years, maintainability of the prosthesis, and what happens when the treatment fails, since a failed zygomatic implant leaves a defect and a failed graft leaves an atrophic maxilla much as before. None of these is captured by the existing randomized trial at one year [14].
9. Implications for Implant Surgery and Restorative Dentistry
Present evidence supports zygomatic implants as an effective treatment for severe maxillary atrophy when performed by surgeons with specific training, and the consensus literature states this [6]. It supports routine preoperative imaging of the sinuses, including the ostiomeatal complex, and consideration of otolaryngologic assessment where disease is present, on the reasoning in Section 5.1 and independent of whether the path hypothesis is confirmed. It supports choosing the implant path according to individual anatomy, as the anatomy-guided approach proposes [24], while recognizing that the claim of fewer sinus complications with extrasinus placement rests on non-randomized comparisons and that soft-tissue recession is the price in some anatomies. Patients should be told that sinus problems can arise years later and should be followed accordingly, with a low threshold for imaging when symptoms occur.
For pterygoid implants, the evidence supports their use to obtain posterior support and eliminate cantilevers where the surgeon is experienced in the region; the absence of systematic complication data should be disclosed. Restorative clinicians should plan for the steep angulation and distal position of the platform, which affect impression procedures, screw access, and hygiene.
In choosing between remote anchorage and grafting, the patient's priorities regarding treatment time and number of procedures, the residual anatomy, sinus health, and the available surgical expertise are legitimate determinants, since survival data do not settle the matter.
10. Technical and Clinical Limitations
The review is narrative, and pooled figures are quoted from reviews whose primary studies are largely retrospective. The risk model is a simplification: path is treated categorically though it is continuous, and mechanisms may interact. The registry is observational, and confounding by indication cannot be eliminated because path is chosen for anatomical reasons that may themselves affect sinus risk; adjustment and restriction reduce this without removing it. Postoperative and surveillance tomography add radiation exposure that must be justified to ethics committees and minimized. The composite outcome may miss mild disease. Five years may be too short for late events. The planning event rate is uncertain, and the registry may prove underpowered for H8c in particular, since few sinuses will have discordant path and count. Participation by expert centers limits generalization to less experienced operators, for whom complication rates are likely higher.
11. Proposed Clinical Validation
The registry is the validation. Its conduct is staged. Stage 1 is a reliability study of the exposure classification: two examiners classify postoperative scans from existing patients, and the classification is adopted only if agreement is substantial. Stage 2 is a retrospective feasibility analysis in two or three centers with existing long-term cohorts and archived imaging, estimating the sinus-level event rate to refine the sample size; this stage can also give an early, lower-quality test of H8a. Stage 3 is the prospective registry. Stage 4, contingent on a supported path effect and on equipoise in anatomies where more than one path is feasible, is a randomized trial of path in those anatomies, with the composite sinus outcome and soft-tissue dehiscence as co-primary outcomes. Refutation criteria are stated in Section 4.
A separate validation need concerns the comparator. Long-term follow-up of the existing randomized trial cohort, and new trials reporting patient-centered outcomes at five and ten years, are required before any claim of superiority of remote anchorage or of grafting can be made.
12. Future Research Directions
Several questions lie beyond the registry. Whether implant surface on the intrasinus portion matters, a machined mid-section being less retentive of biofilm than a rough one, could be studied within the registry if designs vary. Dynamic navigation and robotic guidance may make planned paths more reproducible, which would in turn make path a controllable variable. Patient-specific subperiosteal frameworks have re-emerged as an alternative for the same indication and should be compared in the same outcome framework. For pterygoid implants, basic prospective documentation of morbidity and of long-term peri-implant tissue health is the first need. And for all remote-anchorage strategies, protocols for managing failure deserve study, since revision options are constrained.
13. Evidence-Calibrated Conclusion
Zygomatic implants have cumulative survival of about 95 percent over twelve years in pooled, mostly retrospective series, and pterygoid implants a similar figure over shorter follow-up; the certainty of these estimates is limited by study design and by concentration in expert centers. Rhinosinusitis is the most common complication of zygomatic implants, with incidence that is uncertain because of inconsistent definitions and follow-up. That extrasinus placement reduces sinus morbidity is plausible and unproven. One randomized trial at one year favors zygomatic implants over grafting for implant and prosthesis failure. We have proposed that sinus morbidity is a path-dependent, sinus-level risk, specified a classification and registry capable of testing that proposition, and stated the results that would refute it. The proposal is a hypothesis and a study design; it reports no patient outcomes.
Cite this paper
Jain S, Gupta A. Remote Anchorage for the Severely Atrophic Maxilla: A Critical Review of Zygomatic and Pterygoid Implants and a Sinus-Level Registry Protocol to Test Whether Implant Path, Not Implant Count, Determines Rhinosinusitis Risk. Working paper. Center for Implant Dentistry; 2026. Available from: https://bayareaimplantdentistry.com/clinician-research-and-publications/zygomatic-and-pterygoid-implants-path-stratified-risk
References
- Aghaloo TL, Moy PK. Which hard tissue augmentation techniques are the most successful in furnishing bony support for implant placement? Int J Oral Maxillofac Implants. 2007;22 Suppl:49-70. PMID: 18437791 (opens in a new tab).
- Esposito M, Felice P, Worthington HV. Interventions for replacing missing teeth: augmentation procedures of the maxillary sinus. Cochrane Database Syst Rev. 2014;2014(5):CD008397. doi:10.1002/14651858.CD008397.pub2 (opens in a new tab) PMID: 24825543 (opens in a new tab).
- Brånemark PI, Gröndahl K, Ohrnell LO, Nilsson P, Petruson B, Svensson B, et al. Zygoma fixture in the management of advanced atrophy of the maxilla: technique and long-term results. Scand J Plast Reconstr Surg Hand Surg. 2004;38(2):70-85. doi:10.1080/02844310310023918 (opens in a new tab) PMID: 15202664 (opens in a new tab).
- Balshi TJ, Wolfinger GJ, Balshi SF 2nd. Analysis of 356 pterygomaxillary implants in edentulous arches for fixed prosthesis anchorage. Int J Oral Maxillofac Implants. 1999;14(3):398-406. PMID: 10379114 (opens in a new tab).
- Aparicio C, Manresa C, Francisco K, Claros P, Alández J, González-Martín O, et al. Zygomatic implants: indications, techniques and outcomes, and the zygomatic success code. Periodontol 2000. 2014;66(1):41-58. doi:10.1111/prd.12038 (opens in a new tab) PMID: 25123760 (opens in a new tab).
- Al-Nawas B, Aghaloo T, Aparicio C, Bedrossian E, Brecht L, Brennand-Roper M, et al. ITI consensus report on zygomatic implants: indications, evaluation of surgical techniques and long-term treatment outcomes. Int J Implant Dent. 2023;9(1):28. doi:10.1186/s40729-023-00489-9 (opens in a new tab) PMID: 37698775 (opens in a new tab).
- Chrcanovic BR, Albrektsson T, Wennerberg A. Survival and Complications of Zygomatic Implants: An Updated Systematic Review. J Oral Maxillofac Surg. 2016;74(10):1949-64. doi:10.1016/j.joms.2016.06.166 (opens in a new tab) PMID: 27422530 (opens in a new tab).
- Chrcanovic BR, Abreu MH. Survival and complications of zygomatic implants: a systematic review. Oral Maxillofac Surg. 2013;17(2):81-93. doi:10.1007/s10006-012-0331-z (opens in a new tab) PMID: 22562293 (opens in a new tab).
- Goiato MC, Pellizzer EP, Moreno A, Gennari-Filho H, dos Santos DM, Santiago JF Jr, et al. Implants in the zygomatic bone for maxillary prosthetic rehabilitation: a systematic review. Int J Oral Maxillofac Surg. 2014;43(6):748-57. doi:10.1016/j.ijom.2014.01.004 (opens in a new tab) PMID: 24530034 (opens in a new tab).
- Brennand Roper M, Vissink A, Dudding T, Pollard A, Gareb B, Malevez C, et al. Long-term treatment outcomes with zygomatic implants: a systematic review and meta-analysis. Int J Implant Dent. 2023;9(1):21. doi:10.1186/s40729-023-00479-x (opens in a new tab) PMID: 37405545 (opens in a new tab).
- Polido WD, Machado-Fernandez A, Lin WS, Aghaloo T. Indications for zygomatic implants: a systematic review. Int J Implant Dent. 2023;9(1):17. doi:10.1186/s40729-023-00480-4 (opens in a new tab) PMID: 37391575 (opens in a new tab).
- Kämmerer PW, Fan S, Aparicio C, Bedrossian E, Davó R, Morton D, et al. Evaluation of surgical techniques in survival rate and complications of zygomatic implants for the rehabilitation of the atrophic edentulous maxilla: a systematic review. Int J Implant Dent. 2023;9(1):11. doi:10.1186/s40729-023-00478-y (opens in a new tab) PMID: 37198345 (opens in a new tab).
- Bedrossian E. Rehabilitation of the edentulous maxilla with the zygoma concept: a 7-year prospective study. Int J Oral Maxillofac Implants. 2010;25(6):1213-21. PMID: 21197500 (opens in a new tab).
- Davó R, Felice P, Pistilli R, Barausse C, Marti-Pages C, Ferrer-Fuertes A, et al. Immediately loaded zygomatic implants vs conventional dental implants in augmented atrophic maxillae: 1-year post-loading results from a multicentre randomised controlled trial. Eur J Oral Implantol. 2018;11(2):145-161. PMID: 29806663 (opens in a new tab).
- Molinero-Mourelle P, Baca-Gonzalez L, Gao B, Saez-Alcaide LM, Helm A, Lopez-Quiles J. Surgical complications in zygomatic implants: A systematic review. Med Oral Patol Oral Cir Bucal. 2016;21(6):e751-e757. doi:10.4317/medoral.21357 (opens in a new tab) PMID: 27694789 (opens in a new tab).
- D'Agostino A, Trevisiol L, Favero V, Pessina M, Procacci P, Nocini PF. Are Zygomatic Implants Associated With Maxillary Sinusitis? J Oral Maxillofac Surg. 2016;74(8):1562-73. doi:10.1016/j.joms.2016.03.014 (opens in a new tab) PMID: 27070844 (opens in a new tab).
- Becktor JP, Isaksson S, Abrahamsson P, Sennerby L. Evaluation of 31 zygomatic implants and 74 regular dental implants used in 16 patients for prosthetic reconstruction of the atrophic maxilla with cross-arch fixed bridges. Clin Implant Dent Relat Res. 2005;7(3):159-65. doi:10.1111/j.1708-8208.2005.tb00060.x (opens in a new tab) PMID: 16219246 (opens in a new tab).
- Davó R, Malevez C, López-Orellana C, Pastor-Beviá F, Rojas J. Sinus reactions to immediately loaded zygoma implants: a clinical and radiological study. Eur J Oral Implantol. 2008;1(1):53-60. PMID: 20467644 (opens in a new tab).
- Petruson B. Sinuscopy in patients with titanium implants in the nose and sinuses. Scand J Plast Reconstr Surg Hand Surg. 2004;38(2):86-93. doi:10.1080/02844310310023909 (opens in a new tab) PMID: 15202665 (opens in a new tab).
- Bedrossian E, Bedrossian EA. Prevention and the Management of Complications Using the Zygoma Implant: A Review and Clinical Experiences. Int J Oral Maxillofac Implants. 2018;33(5):e135-e145. doi:10.11607/jomi.6539 (opens in a new tab) PMID: 30231096 (opens in a new tab).
- Nkenke E, Hahn M, Lell M, Wiltfang J, Schultze-Mosgau S, Stech B, et al. Anatomic site evaluation of the zygomatic bone for dental implant placement. Clin Oral Implants Res. 2003;14(1):72-9. doi:10.1034/j.1600-0501.2003.140110.x (opens in a new tab) PMID: 12562368 (opens in a new tab).
- Stella JP, Warner MR. Sinus slot technique for simplification and improved orientation of zygomaticus dental implants: a technical note. Int J Oral Maxillofac Implants. 2000;15(6):889-93. PMID: 11151591 (opens in a new tab).
- Maló P, Nobre Mde A, Lopes I. A new approach to rehabilitate the severely atrophic maxilla using extramaxillary anchored implants in immediate function: a pilot study. J Prosthet Dent. 2008;100(5):354-66. doi:10.1016/S0022-3913(08)60237-1 (opens in a new tab) PMID: 18992569 (opens in a new tab).
- Aparicio C. A proposed classification for zygomatic implant patient based on the zygoma anatomy guided approach (ZAGA): a cross-sectional survey. Eur J Oral Implantol. 2011;4(3):269-75. PMID: 22043470 (opens in a new tab).
- Aparicio C, Manresa C, Francisco K, Aparicio A, Nunes J, Claros P, et al. Zygomatic implants placed using the zygomatic anatomy-guided approach versus the classical technique: a proposed system to report rhinosinusitis diagnosis. Clin Implant Dent Relat Res. 2014;16(5):627-42. doi:10.1111/cid.12047 (opens in a new tab) PMID: 23464749 (opens in a new tab).
- Wang F, Monje A, Lin GH, Wu Y, Monje F, Wang HL, et al. Reliability of four zygomatic implant-supported prostheses for the rehabilitation of the atrophic maxilla: a systematic review. Int J Oral Maxillofac Implants. 2015;30(2):293-8. doi:10.11607/jomi.3691 (opens in a new tab) PMID: 25830389 (opens in a new tab).
- Davó R, David L. Quad Zygoma: Technique and Realities. Oral Maxillofac Surg Clin North Am. 2019;31(2):285-297. doi:10.1016/j.coms.2018.12.006 (opens in a new tab) PMID: 30947849 (opens in a new tab).
- Chrcanovic BR, Oliveira DR, Custódio AL. Accuracy evaluation of computed tomography-derived stereolithographic surgical guides in zygomatic implant placement in human cadavers. J Oral Implantol. 2010;36(5):345-55. doi:10.1563/AAID-JOI-D-09-00074 (opens in a new tab) PMID: 20545538 (opens in a new tab).
- Hung KF, Wang F, Wang HW, Zhou WJ, Huang W, Wu YQ. Accuracy of a real-time surgical navigation system for the placement of quad zygomatic implants in the severe atrophic maxilla: A pilot clinical study. Clin Implant Dent Relat Res. 2017;19(3):458-465. doi:10.1111/cid.12475 (opens in a new tab) PMID: 28219120 (opens in a new tab).
- Bidra AS, Huynh-Ba G. Implants in the pterygoid region: a systematic review of the literature. Int J Oral Maxillofac Surg. 2011;40(8):773-81. doi:10.1016/j.ijom.2011.04.007 (opens in a new tab) PMID: 21601424 (opens in a new tab).
- Bidra AS, Peña-Cardelles JF, Iverson M. Implants in the pterygoid region: An updated systematic review of modern roughened surface implants. J Prosthodont. 2023;32(4):285-291. doi:10.1111/jopr.13600 (opens in a new tab) PMID: 36069239 (opens in a new tab).
- Araujo RZ, Santiago Júnior JF, Cardoso CL, Benites Condezo AF, Moreira Júnior R, Curi MM. Clinical outcomes of pterygoid implants: Systematic review and meta-analysis. J Craniomaxillofac Surg. 2019;47(4):651-660. doi:10.1016/j.jcms.2019.01.030 (opens in a new tab) PMID: 30799134 (opens in a new tab).
- Raouf K, Chrcanovic BR. Clinical Outcomes of Pterygoid and Maxillary Tuberosity Implants: A Systematic Review. J Clin Med. 2024;13(15). doi:10.3390/jcm13154544 (opens in a new tab) PMID: 39124809 (opens in a new tab).
- Balshi TJ, Wolfinger GJ, Slauch RW, Balshi SF. A retrospective comparison of implants in the pterygomaxillary region: implant placement with two-stage, single-stage, and guided surgery protocols. Int J Oral Maxillofac Implants. 2013;28(1):184-9. doi:10.11607/jomi.2693 (opens in a new tab) PMID: 23377065 (opens in a new tab).
- Rodríguez X, Méndez V, Vela X, Segalà M. Modified surgical protocol for placing implants in the pterygomaxillary region: clinical and radiologic study of 454 implants. Int J Oral Maxillofac Implants. 2012;27(6):1547-53. PMID: 23189309 (opens in a new tab).
- Curi MM, Cardoso CL, Ribeiro Kde C. Retrospective study of pterygoid implants in the atrophic posterior maxilla: implant and prosthesis survival rates up to 3 years. Int J Oral Maxillofac Implants. 2015;30(2):378-83. doi:10.11607/jomi.3665 (opens in a new tab) PMID: 25830398 (opens in a new tab).
- Candel E, Peñarrocha D, Peñarrocha M. Rehabilitation of the atrophic posterior maxilla with pterygoid implants: a review. J Oral Implantol. 2012;38 Spec No:461-6. doi:10.1563/AAID-JOI-D-10-00200 (opens in a new tab) PMID: 21568718 (opens in a new tab).
- Rodríguez X, Rambla F, De Marcos Lopez L, Méndez V, Vela X, Jiménez Garcia J. Anatomical study of the pterygomaxillary area for implant placement: cone beam computed tomographic scanning in 100 patients. Int J Oral Maxillofac Implants. 2014;29(5):1049-52. doi:10.11607/jomi.3173 (opens in a new tab) PMID: 25216128 (opens in a new tab).
- Bedrossian E, Sullivan RM, Fortin Y, Malo P, Indresano T. Fixed-prosthetic implant restoration of the edentulous maxilla: a systematic pretreatment evaluation method. J Oral Maxillofac Surg. 2008;66(1):112-22. doi:10.1016/j.joms.2007.06.687 (opens in a new tab) PMID: 18083424 (opens in a new tab).
- von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453-7. doi:10.1016/S0140-6736(07)61602-X (opens in a new tab) PMID: 18064739 (opens in a new tab).
- Hopkins C, Gillett S, Slack R, Lund VJ, Browne JP. Psychometric validity of the 22-item Sinonasal Outcome Test. Clin Otolaryngol. 2009;34(5):447-54. doi:10.1111/j.1749-4486.2009.01995.x (opens in a new tab) PMID: 19793277 (opens in a new tab).
- Lund VJ, Mackay IS. Staging in rhinosinusitus. Rhinology. 1993;31(4):183-4. PMID: 8140385 (opens in a new tab).
- Reference verification note. 42 of 42 references are PubMed-indexed; their bibliographic records (authors, title, journal, year, volume, pages, DOI, PMID) were retrieved programmatically from the PubMed database on November 17, 2026. Database retrieval confirms that each record exists as cited; it does not replace full-text reading by the responsible authors of every statement attributed to a source.

